^○Yuji Tsunekawa¹, Rimi Yoshioka^1,2, Yae Kurosawa^1,3, Takako Sasaki¹, Yuko Kakiuti¹, Mikako Wada¹, Yuko Kasahara¹, Hiromi Kinoh¹, Takashi kada¹ (1.Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, 2.Medical Technology & Material Laboratory, Research and Business Development Division, Asahi Kasei Medical Co, 3.Chromatography Media Management Division, HOYA Technosurgical Corporation)

^○Yuka Hayashi^1,2, Yoshihide Sehara¹, Ryota Wataho¹, Kenji Ohba¹, Yoshio Sakiyama², Hiroaki Mizukami¹ (1.Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, 2.Jichi Medical University Saitama Medical Center)

^○Yuuki Fukai¹, Ayumu Konno^1,2, Yasunori Matsuzaki^1,2, Hirokazu Hirai^1,2 (1.Department of Neurophysiology and Neural Repair, Gunma University Graduate School of Medicine, 2.Viral Vector Core, Gunma University Initiative for Advanced Research (GIAR))

^○Yuya Nishimura¹, Kenji Tsuge², Syunsuke Saito¹ (1.Medical Business Unit, Synprogen Co., Ltd., 2.DNA synthesis Business Unit, Synprogen Co., Ltd.)

^○HIroyuki Nakai^1,2, Christina Chatzi¹, Dhwanil Dalwadi¹, Samuel J Huang², Yasunori Matsuzaki³, Hirokazu Hirai³ (1.Capsigen Inc., 2.Oregon Health & Science University, 3.Gunma University Graduate School of Medicine)

^○Rachael Lake Hardison, Frank Agbogbo, Steven Wesel, Ganesh Krishnamoorthy, David Dismuke (Forge Biologics)